CNIO - Spanish National Cancer Research Centre
Nuria Romero Laorden is an Associated Clinical Investigator at the Spanish National Cancer Research Centre (CNIO) since February 2015, specializing in Translational Oncology within the Prostate and Genitourinary Cancer Unit, focusing on biomarkers development and DNA repair processes. Since June 2017, Nuria has served as a Medical Oncologist at Hospital Universitario La Princesa, concentrating on Genitourinary Tumors and Clinical Trials, while also holding a position at Centro Integral Oncológico Clara Campal since 2012, where responsibilities include clinical research and patient assistance in the Prostate Cancer and Genetic Counselling Unit. Previous experience includes a locum position at Hospital Universitario Fundación Alcorcón and clinical observership at NYU Langone Medical Center. Educational credentials include a Bachelor of Applied Science in Medicine from Universidad Complutense de Madrid, a Doctorate and a Master of Science in Clinical Research from Universidad Rey Juan Carlos, and formal medical oncology specialty training at Hospital Universitario Fundación Alcorcón.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.